SCHEMBL7891804

SCHEMBL7891804

COc1ccc(C2c3ccsc3CCN2C(=O)c2ccc(F)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ LHCGR P22888 11/20 0.64
▸ POLB P06746 1/20 0.63
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ CNR1 P21554 1/20 0.52
▸ CA12 O43570 1/20 0.52
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ CA7 P43166 1/20 0.52
▸ CA9 Q16790 1/20 0.52
▸ CA14 Q9ULX7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7891790 0.94 POLB (0.69) LHCGRPOLBMEN1KMT2ACNR1
SCHEMBL7885853 0.89 LHCGR (0.73) LHCGRPOLBMEN1KMT2A
SCHEMBL7880463 0.89 LHCGR (0.73) LHCGRPOLBMEN1KMT2A
SCHEMBL7880265 0.89 HHAT (0.65) LHCGRPOLBCA12CA1CA2
SCHEMBL7880417 0.89 POLB (0.63) LHCGRPOLB
SCHEMBL7887385 0.89 POLB (0.63) LHCGRPOLBMEN1KMT2ACNR1
SCHEMBL7880530 0.89 POLB (0.63) LHCGRPOLB
SCHEMBL7880311 0.88 POLB (0.61) LHCGRPOLBMEN1KMT2ACNR1
SCHEMBL7888190 0.88 POLB (0.61) LHCGRPOLBMEN1KMT2ACNR1
SCHEMBL7889885 0.88 POLB (0.61) LHCGRPOLBMEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177443-B1 ANTIDIABETIC AGENTS NOVO NORDISK A/S (DK) 2001-01-23 — — US disclosed
EP-0973778-A1 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 2000-01-26 — — EP disclosed
WO-1998040385-A1 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1998-09-17 — — WO disclosed
Send feedback